Padma Kodukula Email & Phone Number

Del Mar, Ca, Us

A-Alpha Bio leverages synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions. Our AlphaSeq + AlphaBind platforms generate and synthesize the high-resolution data needed to discover and optimize rare and effective antibodies, identify compatible protein pairs for molecular glues, and fuel machine-learning models to further accelerate the discovery and optimization of high-impact drugs.We are seeking strategic partnerships to… Show more A-Alpha Bio leverages synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions. Our AlphaSeq + AlphaBind platforms generate and synthesize the high-resolution data needed to discover and optimize rare and effective antibodies, identify compatible protein pairs for molecular glues, and fuel machine-learning models to further accelerate the discovery and optimization of high-impact drugs.We are seeking strategic partnerships to discover and optimize the next generation of high-impact biologic drugs. Show less

Vancouver, British Columbia, Canada

• Lead the corporate & business development strategy to drive incremental value and deliver on the company’s vision and growth objectives.• Seek, negotiate, and execute on company’s platform technology licensing, co-development and collaboration deals for lipid nanoparticle drug delivery and manufacturing of nanoparticle based genetic medicines.• Secured $35M in grant funding from the Strategic Innovation Fund Canada for COVID vaccine development and genetic medicines biomanufacturing… Show more • Lead the corporate & business development strategy to drive incremental value and deliver on the company’s vision and growth objectives.• Seek, negotiate, and execute on company’s platform technology licensing, co-development and collaboration deals for lipid nanoparticle drug delivery and manufacturing of nanoparticle based genetic medicines.• Secured $35M in grant funding from the Strategic Innovation Fund Canada for COVID vaccine development and genetic medicines biomanufacturing center build. Show less

Greater San Diego Area

Now renamed Cygenex, GeneTox Lab Solutions is a genetic testing, precision medicine and data analytics company working to help healthcare organizations manage their patient populations. As a founding board member I was responsible for mentoring the company co-founders through company incorporation, strategic planning, and sales and marketing efforts.

Greater San Diego Area

Human Longevity Inc. is a health intelligence company using advanced genomics-based information to empower individuals to shape their own health and shift the practice of medicine from reactive to proactive, personalized, and preventative. At HLI, I seek, negotiate and execute on collaborative partnerships with pharma, academia and health systems to deliver on the promise of genomics and data analytics in revolutionizing health care.

Responsible for collaborative partnerships related to qPCR and CE platforms that includes seeking, negotiating, closing and executing several deals with molecular diagnostic and pharmaceutical companies.

Responsible for leading the project management department and involved in managing key strategic alliances.

Led the Program Management Office (PMO) including the planning, execution, and reporting of multiple development programs, partnerships (Eli Lilly) and two diagnostic product launches.

Member of the award winning Sutent team that successfully completed a NDA filing in 2005. Supported all supply chain management activities of manufacturing of Sutent (Sunitinib) drug product for two pivotal Phase III studies and over 15 Phase I and II studies.

Alliance manager for major collaborations including NCI (National Cancer Institute) and CANVAC (Canadian Network for Vaccines and Immunotherapeutics) towards the co-development and commercialization of antibodies and immune function assay kits.

Ph.D., Viral Immunology

Mba